Novolog and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported as a side effect among people who take Novolog (insulin aspart recombinant), especially for people who are female, 60+ old, also take Lantus, and have Chest pain.

The phase IV clinical study analyzes which people have Hyperventilation when taking Novolog. It is created by eHealthMe based on reports of 55,653 people who have side effects when taking Novolog from the FDA, and is updated regularly.

What is Novolog?

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. eHealthMe is studying from 56,160 Novolog users. Check the latest studies of Novolog.

What is Hyperventilation?

Hyperventilation is found to be associated with 706 drugs and 1,444 conditions by eHealthMe. Check the latest studies of Hyperventilation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

55,653 people reported to have side effects when taking Novolog.
Among them, 19 people (0.03%) have Hyperventilation.

Among these 19 people:

What is the gender of people who have Hyperventilation when taking Novolog? *

female: 68.42 %
male: 31.58 %

What is the age of people who have Hyperventilation when taking Novolog? *

What are other drugs people take besides Novolog? *

What are other side effects people have besides Hyperventilation? *

Tremor (trembling or shaking movements in one or more parts of your body): 7 people, 36.84%
Acute Kidney Failure: 5 people, 26.32%
Blood Glucose Increased: 5 people, 26.32%
Abdominal Pain: 4 people, 21.05%
Weakness: 4 people, 21.05%
Memory Loss: 4 people, 21.05%
Stress And Anxiety: 4 people, 21.05%
Fever: 4 people, 21.05%
Dyspnea (difficult or laboured breathing): 4 people, 21.05%
Nausea And Vomiting: 3 people, 15.79%

What are the existing conditions these people have? *

Chest Pain: 3 people, 15.79%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 10.53%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 10.53%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 10.53%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 10.53%
Weight Decreased: 1 person, 5.26%
Sleep Apnea Syndrome: 1 person, 5.26%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 5.26%
Quit Smoking: 1 person, 5.26%
Insomnia (sleeplessness): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Novolog and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novolog:

Novolog (56,160 reports)

Browse all side effects of Novolog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (706 drugs)

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,444 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant (the active ingredients of Novolog) and Novolog (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.